Heartworm disease remains one of the most consequential parasitic threats facing dogs worldwide, and a new study published in the journal Parasites & Vectors suggests that detecting it at the point of care may now be faster and more reliable than ever. A team of researchers at Mars Petcare Science & Diagnostics and Antech Diagnostics has evaluated the trūRapid™ FOUR heartworm antigen test, a rapid lateral flow immunoassay designed to identify infection with Dirofilaria immitis, the mosquito-borne nematode responsible for canine heartworm disease. Their findings indicate that the test achieves diagnostic performance essentially indistinguishable from a well-established laboratory reference assay, while delivering results in just ten minutes.
The clinical challenge that motivates this work is well known to veterinary practitioners. Dogs infected with D. immitis typically show no overt clinical signs in the early stages of infection, a period during which adult worms are maturing in the pulmonary arteries and heart. By the time coughing, exercise intolerance, or weight loss appear, disease progression may already be advanced, and the prognosis can be poor. Because treatment of established heartworm infection is costly, prolonged, and carries its own risks, early detection through routine screening is a cornerstone of veterinary preventive medicine. Annual antigen testing is widely recommended, which places point-of-care tests at the center of everyday clinical practice.
The biology underlying the diagnostic approach is worth unpacking. Adult female D. immitis worms release specific glycoprotein antigens into the host’s bloodstream, primarily into the reproductive tract of the parasite and subsequently into circulating blood. Antigen tests detect these molecules rather than antibodies, which means a positive result indicates the presence of actively reproducing adult female worms rather than mere prior exposure. This is the principle shared by the three assays compared in the study: the trūRapid™ FOUR test manufactured by Antech Diagnostics, the SNAP® 4DX® Plus test from IDEXX, and the DiroCHEK® assay from Zoetis, which served as the reference standard.
To assess how well the new test performs, the researchers evaluated a total of 350 canine remnant serum samples. Each sample was run through all three assays according to the manufacturers’ instructions, allowing direct head-to-head comparison. Using DiroCHEK®, a microtiter plate ELISA widely regarded as a reference laboratory method, the panel included 149 samples that tested positive for D. immitis antigen and 201 samples that tested negative. This design allowed the team to calculate both sensitivity, the ability to correctly identify infected dogs, and specificity, the ability to correctly identify uninfected ones, with meaningful statistical confidence.
The results were striking. For the 149 DiroCHEK®-positive samples, the trūRapid™ FOUR test demonstrated a sensitivity of 98.7 percent, with a 95 percent confidence interval spanning 94.3 to 99.6 percent. In practical terms, the test missed only a small fraction of antigen-positive samples, and the upper bound of the confidence interval approached perfection. Among the 201 samples that were negative on the reference assay, the trūRapid™ FOUR test achieved a specificity of 100 percent, with a 95 percent confidence interval of 98.2 to 100 percent, meaning it produced no false positives in this sample set. For a screening test intended for annual use in apparently healthy dogs, that combination of high sensitivity and perfect observed specificity is exactly the profile clinicians hope to see.
Agreement with an established point-of-care competitor was equally strong. When trūRapid™ FOUR results were compared directly with those of the SNAP® 4DX® Plus, the two tests showed almost perfect concordance, with an agreement coefficient of 0.994 and a 95 percent confidence interval of 0.983 to 1.000. Values this close to 1.0 indicate that, across the entire sample panel, the two point-of-care assays essentially never disagreed in a way that would change a clinical decision. For veterinarians, this means switching to or adding the new test is unlikely to alter diagnostic outcomes relative to the platforms already in widespread use.
Speed and workflow matter as much as raw accuracy in the exam room. The trūRapid™ FOUR test delivers a result in approximately ten minutes, which allows a veterinarian to test a dog during a single appointment and act on the result immediately, whether that means counseling an owner about treatment or confirming that a prevention plan is working. The study’s authors conclude that the test provides reliable diagnostic accuracy, ease of use, and a fast time to result, making it a robust point-of-care option for detecting canine heartworm infection. They note that its performance is comparable both to the reference laboratory ELISA, DiroCHEK®, and to the commercially available SNAP® 4DX® Plus.
The implications extend beyond a single product evaluation. Point-of-care diagnostics have transformed veterinary medicine by moving testing out of centralized laboratories and into clinics, shelters, and field settings. In regions where heartworm is endemic, including much of the southeastern United States and expanding areas of Europe, Asia, and South America, the ability to screen reliably without shipping samples or waiting days can increase testing rates and catch infections earlier. Shelter medicine and rescue transport programs, in particular, depend on rapid, accurate screening to make sound decisions about animal movement and treatment. A validated ten-minute assay that matches laboratory performance strengthens that infrastructure.
As with any diagnostic study, context matters. The evaluation was conducted on remnant serum samples rather than whole blood drawn in a clinic, and the sample panel was defined by the reference test’s own results, so sensitivity and specificity are measured relative to DiroCHEK® rather than to an independent gold standard such as necropsy confirmation. The research was funded by Antech Diagnostics and Mars Petcare Science & Diagnostics, and the authors declared no competing interests; readers should weigh the funding source when interpreting the uniformly favorable results, even though the comparison against an independent manufacturer’s test provides a useful external benchmark. Confidence intervals, which the authors report transparently, also remind us that a 100 percent observed specificity in 201 samples still carries a small margin of statistical uncertainty.
Nevertheless, the study adds a credible new option to the veterinary diagnostic toolkit at a time when heartworm’s geographic footprint continues to shift with climate and animal movement. The findings support the use of the trūRapid™ FOUR heartworm antigen test as a dependable clinical tool for the detection and management of heartworm infection in dogs, and they underscore a broader trend: rapid immunoassays are closing the gap with laboratory reference methods. For the millions of dog owners whose pets receive annual heartworm screening, the practical takeaway is simple. The test that runs in the exam room while you wait is now backed by evidence that it performs on par with the reference laboratory, and earlier, more accessible detection remains the best defense against a disease that is far easier to prevent than to cure.
Subject of Research: Evaluation of a rapid point-of-care antigen test for detecting Dirofilaria immitis heartworm infection in dogs
Article Title: Evaluation of the trūRapid™ FOUR heartworm antigen test: a reliable point-of-care diagnostic tool for heartworm detection in dogs
Article References: Evaluation of the trūRapid™ FOUR heartworm antigen test: a reliable point-of-care diagnostic tool for heartworm detection in dogs. (n.d.). https://doi.org/10.1186/s13071-026-07630-8
Image Credits: AI Generated
DOI: 10.1186/s13071-026-07630-8
Keywords: Dirofilaria immitis, heartworm disease, canine diagnostics, point-of-care testing, lateral flow immunoassay, antigen test, trūRapid FOUR, DiroCHEK, SNAP 4DX Plus, veterinary parasitology, diagnostic sensitivity, Parasites & Vectors
News Source: William Thompson. (October 8, 2026). New 10-Minute Test Matches Lab Gold Standard for Detecting Heartworm in Dogs. Scienmag.
